120 related articles for article (PubMed ID: 26829282)
1. Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers: a prospective analysis.
Fadel FI; Elshamaa MF; Abdel-Rahman SM; Thabet EH; Kamel S; Kandil D; Ibrahim MH; El-Ahmady M
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):190-8. PubMed ID: 26829282
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-anti-thrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis.
Milburn JA; Ford I; Mutch NJ; Fluck N; Brittenden J
PLoS One; 2013; 8(7):e67799. PubMed ID: 23844096
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilia and arteriovenous fistula survival in ESRD.
Salmela B; Hartman J; Peltonen S; Albäck A; Lassila R
Clin J Am Soc Nephrol; 2013 Jun; 8(6):962-8. PubMed ID: 23411429
[TBL] [Abstract][Full Text] [Related]
4. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of coagulation and fibrinolysis can predict vascular access failure in patients on hemodialysis after vascular access intervention.
Hasuike Y; Kakita N; Aichi M; Masachika S; Kantou M; Ikeda Takahashi S; Nanami M; Nagasawa Y; Kuragano T; Nakanishi T
J Vasc Surg; 2019 Jan; 69(1):174-180.e2. PubMed ID: 29914835
[TBL] [Abstract][Full Text] [Related]
6. Thrombophilia in sickle cell disease: the red cell connection.
Setty BN; Rao AK; Stuart MJ
Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience.
Anapalli SR; N HD; Sarma P; Srikanth L; V SK
Ren Fail; 2022 Dec; 44(1):34-42. PubMed ID: 35094650
[TBL] [Abstract][Full Text] [Related]
8. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
9. Legg-Calve-Perthes disease and thrombophilia.
Balasa VV; Gruppo RA; Glueck CJ; Wang P; Roy DR; Wall EJ; Mehlman CT; Crawford AH
J Bone Joint Surg Am; 2004 Dec; 86(12):2642-7. PubMed ID: 15590848
[TBL] [Abstract][Full Text] [Related]
10. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment.
Tomura S; Nakamura Y; Deguchi F; Ando R; Chida Y; Marumo F
Thromb Res; 1991 Oct; 64(1):81-90. PubMed ID: 1776141
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.
Geenen RW; Delaere KP; van Wersch JW
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):69-72. PubMed ID: 9056745
[TBL] [Abstract][Full Text] [Related]
12. TAT and PAP in hemodialysis patients: two cats in a bag?
Haznedaroğlu IC; Erdem Y; Dündar S; Cağlar S; Kirazh S
Thromb Res; 1995 Dec; 80(5):447-9. PubMed ID: 8588208
[No Abstract] [Full Text] [Related]
13. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
14. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
Erdem Y; Haznedaroglu IC; Celik I; Yalcin AU; Yasavul U; Turgan C; Caglar S
Nephrol Dial Transplant; 1996 Jul; 11(7):1299-305. PubMed ID: 8672026
[TBL] [Abstract][Full Text] [Related]
15. Correlation between clotting and collagen metabolism markers in rheumatoid arthritis.
Gabazza EC; Osamu T; Yamakami T; Ibata H; Sato T; Sato Y; Shima T
Thromb Haemost; 1994 Feb; 71(2):199-202. PubMed ID: 7514817
[TBL] [Abstract][Full Text] [Related]
16. Plasma D-Dimer Level and the Failure of Forearm Autologous Arteriovenous Fistula in Patients With End-Stage Renal Disease.
Du J; Kong X; Liang L; Chen Q; Yin L; Xu D
Ther Apher Dial; 2020 Aug; 24(4):400-407. PubMed ID: 31705787
[TBL] [Abstract][Full Text] [Related]
17. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
18. Anticardiolipin antibodies in children on chronic haemodialysis.
Sallam S; Wafa E; el-Gayar A; Sobh M; Salama O
Nephrol Dial Transplant; 1994; 9(9):1292-4. PubMed ID: 7816292
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
20. Soluble adhesion molecules as markers of native arteriovenous fistula thrombosis in children on uremia.
Fadel FI; Elshamaa MF; Nabhan MM; Essam RG; Kantoush N; El Sonbaty MM; Raafat M; Abd-El Haleem DA
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):675-82. PubMed ID: 24806324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
